PPARγ signaling is connected to the inhibition of inflammatory markers (COX-2, cytokines, and inducible nitric oxide synthase), PI3K/Akt pathway, and angiogenesis while inducing CDK inhibitors, differentiation and apoptosis markers in cancers [79]. Here, PPARG is linked to cancer.